Psoriasis and multiple sclerosis: Is there a link?

Journal of Cutaneous Medicine and Surgery

Volumn 14, Issue 4, 2010, Pages 151-155

  Kwok, Tiffany ^a   Loo, Wei Jing ^a   Guenther, Lyn ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 12P40; INTERLEUKIN 23 RECEPTOR; LENERCEPT;

DISEASE ASSOCIATION; GENETIC POLYMORPHISM; HIGH RISK POPULATION; HUMAN; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; REVIEW; SYSTEMATIC REVIEW; TH17 CELL;

COMORBIDITY; HUMANS; MULTIPLE SCLEROSIS; PREVALENCE; PSORIASIS; TH17 CELLS;

EID: 77955440508     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2010.09063     Document Type: Review

References (29)

1. Warren S, Warren KG. Multiple sclerosis and associated diseases: a relationship to diabetes mellitus. Can J Neurol Sci 1981;8:35-9.
2. Midgard R, Gronning M, Riise T, et al. Multiple sclerosis and chronic inflammatory diseasese: a case-control study. Acta Neurol Scand 1996;93:322-8.
3. Seyfert S, Klapps P, Meisel C, et al. Multiple sclerosis and chronic inflammatory diseases. Acta Neurol Scand 1996;93:322-8.
4. Laroni A, Calabrese M, Perini P, et al. Multiple sclerosis and autoimmune diseases: epidemiology and HLA-DR association in north-east Italy. J Neurol 2006;253:636-9.
5. Alonso A, Hernan MA, Ascherio A. Allergy, family history of autoimmune diseases, and the risk of multiple sclerosis. Acta Neurol Scand 2008;117:15-20.
6. Henderson RD, Bain CJ, Pender MP. The occurrence of autoimmune diseases in patients with multiple sclerosis and their families. J Clin Neurosci 2000;7:434-7.
7. Gottlieb AB, Chao C, Dann F. Psoriatic comorbidities. J Dermatolog Treat 2008;19:5-21.
8. Cendrowski W. [Multiple sclerosis and psoriasis]. Wiad Lek 1989;56:819-22.
9. Barcellos LF, Kamdar BB, Ramsay PP, et al. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. Lancet Neurol 2006;5:924-31.
10. Ramagopalan SV, Dyment DA, Valdar W, et al. Autoimmune disease in families with multiple sclerosis: a population-based study. Lancet Neurol 2007;6:604-10.
11. Criswell LA, Pfeiffer KA, Lum RF, et al. Analysis of families in the Multiple Autoimmune Disease Genetics Consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005;76:561-70.
12. Annunziata P, Morana P, Giorgio A, et al. High frequency of psoriasis in relatives is associated with early onset in an Italian multiple sclerosis cohort. Acta Neurol Scand 2003;108:327-31.
13. Broadley SA, Deans J, Saweer SJ, et al. Autoimmune disease in first-degree relatives of patients with multiple sclerosis: a UK survey. Brain 2000;123:1102-11.
14. Alemany-Rodriguez MJ, Aladro Y, Amela-Peris R, et al. [Autoimmune diseases and multiple sclerosis]. Rev Neurol 2005;40:594-7.
15. Webster GF, Knobler RL, Lublin FD, et al. Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis. J Am Acad Dermatol 1996;34:365-7.
16. Navne JE, Hedegaard U, Bygum A. [Activation of psoriasis in patients undergoing treatment with interferon beta]. Ugeskr Laeger 2005;167:2903-4.
17. Lopez-Lerma I, Iranzo P, Herrero C. New-onset psoriasis in a patient treated with interferon beta-1a. Br J Dermatol 2009;160:716-7.
18. Sukal SA, Nadiminiti L, Granstein RD. Etanercept and demyelinating disease in a patient with psoriasis. J Am Acad Dermatol 2006;54:160-4.
19. Gomez-Gallego M, Meca-Lallana J, Fernandez-Barreiro A. Multiple sclerosis onset during etanercept treatment. Eur Neurol 2008;59:91-3.
20. Ruiz-Jimeno T, Carvajal A, Mata C, Aurrecoechea E. Demyelinating disease in a patient with psoriatic arthritis and family history of multiple sclerosis treated with infliximab. J Rheumatol 2006;33:1457-8.
21. TNF neutralization in MS: results of a randomizedplacebocontrolled multicenter study. The Lenercept Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group. Neurology 1999;53:457-65.
22. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev 2008;223:87-113.
23. Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007;80:273-90.
24. Begovich AB, Chang M, Caillier SJ, et al. The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis. Hum Immunol 2007;68:934-7.
25. Nuñez C, Dema B, Cenit MC, et al. IL23R: a susceptibility locus for celiac disease and multiple sclerosis? Genes Immun 2008;9:289-93.
26. Stern RS, Nijsten T, Feldman SR, et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Invest Dermatol Symp Proc 2004;9:136-9.
27. Ferrándiz C, Bordas X, Garcia Patos V, et al. Prevalence of psoriasis in Spain (Epiderma project: phase 1). J Eur Acad Dermatol 2001;15:20-3.
28. Gelfand JM, Weinstein R, Porter SB, et al. Prevalence and treatment of psoriasis in the United Kingdom. Arch Dermatol 2005;141:1537-41.
29. Finzi AF, Benelli C. A clinical survey of psoriasis in Italy: 1st AISP report. J Eur Acad Dermatol Venereol 1998;10:125-9.